Bladder cancer most commonly presents as painless blood in the urine (hematuria). Risk factors include smoking, occupational exposure to chemicals, and chronic bladder irritation; it has a high recurrence rate.
Pembrolizumab is an immune checkpoint inhibitor that unleashes the immune system against cancer cells, used in melanoma, lung cancer, and other malignancies.
Nivolumab is an immune checkpoint inhibitor that unleashes the immune system against cancer cells, used in melanoma, lung cancer, and other malignancies.
Ipilimumab is an immune checkpoint inhibitor that unleashes the immune system against cancer cells, used in melanoma, lung cancer, and other malignancies.
Atezolizumab is an immune checkpoint inhibitor that unleashes the immune system against cancer cells, used in melanoma, lung cancer, and other malignancies.
Describe your symptoms and get a structured AI clinical assessment — possible causes, urgency level, and recommended next steps.
Start Free AI Analysis →Content on this page is informed by evidence-based clinical sources including: